StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BRKB.WA$1735.60-0.18%
Fair $1735.60+0.0%

BRKB.WA

Berkshire Hathaway Inc.

Financial Services / Insurance - DiversifiedWarsaw

$1735.60

-3.20 (-0.18%)

Fairly Valued+0.0%Fair Value $1735.60Fund rank 33/100 · Data gapFallback financials|
SA 43/C
F-Score: 3/9
Declining Revenue

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 46.0/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 61/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. Revenue has declined for 2 consecutive years
Thesis & Journal · BRKB.WALocal privado en este navegador · Berkshire Hathaway Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.74T

P/E

14.2x

↑

EV/EBITDA

N/A

•

ROE

9.3%

↑

Gross Margin

N/A

•

Debt/Equity

0.18

↓
52-Week Range$1736
$1689$1885

TradingView lightweight chart

BRKB.WA price, volumen y niveles de valoración

Último $1,736Periodo -4.8%
Fair value: $1,736

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+20.6%

FCF CAGR

+4.6%

FCF margin

6.1%

FCF / Net income

0.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $410.52B · net income $66.97B · FCF $25.04B

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

16.3%+26.0% pts

FCF margin

6.1%-3.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$410.52B$410.52B$424.23B$439.34B$234.12B
Net Income$66.97B$66.97B$89.00B$96.22B$-22.76B
EPS31.0431.0461900.0066412.00-10.33
Net Margin16.3%16.3%21.0%21.9%-9.7%
Balance Sheet
Debt/Equity0.180.180.190.230.26
Current Ratio2.882.88———
Cash Flow
Free Cash Flow$25.04B$25.04B$11.62B$29.79B$21.89B
Returns
ROE9.3%9.3%13.7%17.1%-4.8%
Valuation
P/E14.1614.16———
P/B5.225.22———
Growth & Yield
Revenue Growth-3.2%-3.2%-3.4%87.7%—
EPS Growth-99.9%-99.9%-6.8%643045.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

70.6%

muy exigente

EPS terminal req.

$154.01

Spread vs growth

-170.5%

5Y implied EPS CAGR

43.1%

muy exigente

EPS terminal req.

$186.35

Spread vs growth

-143.1%

10Y implied EPS CAGR

25.5%

muy exigente

EPS terminal req.

$300.11

Spread vs growth

-125.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -4.8%

Total return

-4.8%

Start / end P/E

0.0x → 55.9x

EPS bridge

61900.00 → 31.04

Residual

-189547.8%

EPS growth-99.9%
Multiple rerating+189642.9%
Dividend+0.0%
Residual / FX / buybacks / cross-term-189547.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.